Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Percival

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Molecular Biology of the Cell|March 13, 2003
Specification of actin filament function and molecular composition by tropomyosin isoformsNicole S Bryce, Galina Schevzov, Vicki Ferguson, et al.
Open Forum Infectious Diseases|July 19, 2023
Epidemiology of Gram-Negative Bloodstream Infections in the United States: Results From a Cohort of 24 HospitalsDilek Ince, Suiyini Fiawoo, Rebecca Choudhury, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 12, 2023
Defining the Optimal Duration of Therapy for Hospitalized Patients With Complicated Urinary Tract Infections and Associated BacteremiaJohn McAteer, Jae Hyoung Lee, Sara E Cosgrove, et al.
Annals of Hematology|May 9, 2026
Impact of diagnosis-to-treatment interval on the outcome of patients with acute myeloid leukemiaSamah Nassereddine, Yuan Feng, Jordan Selep, et al.
Haematologica|July 11, 2020
Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibilityMary-Elizabeth M Percival, Megan Othus, Sarah Mirahsani, et al.
Leukemia|January 21, 2022
Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignanciesNoam E Kopmar, Megan Othus, Kelda M Gardner, et al.
Leukemia|November 14, 2019
Need for routine examination of left ventricular ejection fraction in patients with AMLHiba M Khan, Kelda M Gardner, Carole Shaw, et al.
Leukemia & Lymphoma|February 21, 2020
Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasmRaffaele Palmieri, Sarah A Buckley, Megan Othus, et al.
Leukemia|February 17, 2022
Physician and patient perceptions on randomization of treatment intensity for unfit adults with acute myeloid leukemia and other high-grade myeloid neoplasmAnna B Halpern, Megan Othus, Genevieve Alcorn, et al.
Bone Marrow Transplantation|April 21, 2015
Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profileMary-Elizabeth M Percival, Bruno C Medeiros, Lu Tian, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Molecular Biology of the Cell|March 13, 2003
Specification of actin filament function and molecular composition by tropomyosin isoformsNicole S Bryce, Galina Schevzov, Vicki Ferguson, et al.
Open Forum Infectious Diseases|July 19, 2023
Epidemiology of Gram-Negative Bloodstream Infections in the United States: Results From a Cohort of 24 HospitalsDilek Ince, Suiyini Fiawoo, Rebecca Choudhury, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 12, 2023
Defining the Optimal Duration of Therapy for Hospitalized Patients With Complicated Urinary Tract Infections and Associated BacteremiaJohn McAteer, Jae Hyoung Lee, Sara E Cosgrove, et al.
Annals of Hematology|May 9, 2026
Impact of diagnosis-to-treatment interval on the outcome of patients with acute myeloid leukemiaSamah Nassereddine, Yuan Feng, Jordan Selep, et al.
Haematologica|July 11, 2020
Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibilityMary-Elizabeth M Percival, Megan Othus, Sarah Mirahsani, et al.
Leukemia|January 21, 2022
Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignanciesNoam E Kopmar, Megan Othus, Kelda M Gardner, et al.
Leukemia|November 14, 2019
Need for routine examination of left ventricular ejection fraction in patients with AMLHiba M Khan, Kelda M Gardner, Carole Shaw, et al.
Leukemia & Lymphoma|February 21, 2020
Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasmRaffaele Palmieri, Sarah A Buckley, Megan Othus, et al.
Leukemia|February 17, 2022
Physician and patient perceptions on randomization of treatment intensity for unfit adults with acute myeloid leukemia and other high-grade myeloid neoplasmAnna B Halpern, Megan Othus, Genevieve Alcorn, et al.
Bone Marrow Transplantation|April 21, 2015
Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profileMary-Elizabeth M Percival, Bruno C Medeiros, Lu Tian, et al.
Pageof 12